Sporadic Inclusion-Body Myositis: Clinical Symptoms, Physical Findings, and Diagnostic Investigations

Muscle Aging, Inclusion-Body Myositis and Myopathies

Volumn , Issue , 2011, Pages 159-167

  Mastaglia, Frank L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Autoantibodies; Clinical signs; Diagnosis; Early symptoms; Electromyography; EMG; Magnetic resonance imaging; MRI; Sporadic inclusion body myositis

Indexed keywords

EID: 84864495509     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444398311.ch9     Document Type: Chapter

References (42)

1. NeedhamM, Mastaglia FL. (2007) Inclusion bodymyositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 6(7), 620-631.
2. Amato AA, Barohn RJ. (2009) Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 80(11), 1186-1193.
3. Needham M, James I, Corbett A et al. (2008) Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 79(9), 1056-1060.
4. Peng A, Koffman BM, Malley JD, Dalakas MC. (2000) Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 55(2), 296-298.
5. Rose MR, McDermott MP, Thornton CA et al. (2001) A prospective natural history study of inclusion body myositis: implications for clinical trials. Neurology 57 (3), 548-550.
6. Badrising UA, Maat-Schieman ML, van Houwelingen JC et al. (2005) Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 252(12), 1448-1454.
7. Jackson CE, Barohn RJ, Gronseth G et al. (2008) Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 37(4), 473-476.
8. Lotz BP, Engel AG, Nishino H et al. (1989) Inclusion body myositis. Observations in 40 patients. Brain 112 (3), 727-747.
9. Cox FM, Verschuuren JJ, Verbist BM et al. (2009) Detecting dysphagia in inclusion body myositis. J Neurol 256(12), 2009-2013.
10. Cherin P, Pelletier S, Teixeira A et al. (2002) Intravenous immunoglobulin for dysphagia of inclusion body myositis. Neurology 58(2), 326.
11. Oh TH, Brumfield KA, Hoskin TL et al. (2007) Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 82(4), 441-447.
12. Felice KJ, Relva GM, Conway Sr., (1998) Further observations on forearm flexor weakness in inclusion body myositis. Muscle Nerve 21(5), 659-661.
13. Hund E, Heckl R, Goebel HH, Meinck HM. (1995) Inclusion body myositis presenting with isolated erector spinae paresis. Neurology 45(5), 993-994.
14. Lindberg C, Oldfors A, Hedstrom A. (1990) Inclusion body myositis: peripheral nerve involvement. Combined morphological and electrophysiological studies on peripheral nerves. J Neurol Sci 99(2-3) 327-338.
15. Amato AA, Gronseth GS, Jackson CE et al. (1996) Inclusion body myositis: clinical and pathological boundaries. Ann Neurol 40(4), 581-586.
16. Khurana H, Luciano CA. (1996) Nerve conduction studies in inclusion body myositis: Observations in patients. Muscle Nerve 19(9), 1192.
17. Koffman BM, Rugiero M, Dalakas MC. (1998) Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 21(1), 115-117.
18. McCoy AL, Bubb MR, Plotz PH, Davis JC. (1999) Inclusion body myositis long after dermatomyositis: a report of two cases. Clin Exp Rheumatol 17(2), 235-239.
19. Cupler EJ, Leon-Monzon M, Miller J et al. (1996) Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 119 (Pt 6), 1887-1893.
20. Dalakas MC, Illa I. (1995) Common variable immunodeficiency and inclusion body myositis: a distinct myopathy mediated by natural killer cells. Ann Neurol 37(6), 806-810.
21. Cherin P, Menard D, Mouton P et al. (2001) Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases. Neuromuscul Disord 11(5), 452-457.
22. Danon MJ, Perurena OH, Ronan S, Manaligod Jr., (1986) Inclusion body myositis associated with systemic sarcoidosis. Can J Neurol Sci 13(4), 334-336.
23. Kovacs GG, Lindeck-Pozza E, Chimelli L et al. (2004) Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle. Ann Neurol 55(1), 121-125.
24. Askanas V, Engel WK, Alvarez RB et al. (2000) Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele. Ann Neurol 47(4), 544-549.
25. Buchbinder R, Forbes A, Hall S et al. (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134(12), 1087-1095.
26. Parissis D, Karkavelas G, Taskos N, Milonas I. (2003) Inclusion body myositis in a patient with a presumed diagnosis of post-polio syndrome. J Neurol 250(5), 619-621.
27. Griggs RC, Askanas V, DiMauro S et al. (1995) Inclusion body myositis and myopathies. Ann Neurol 38(5), 705-713.
28. Lindberg C, Klintberg L, Oldfors A. (2006) Raised troponin T in inclusion body myositis is common and serum levels are persistent over time. Neuromuscul Disord 16(8), 495-497.
29. Abdo WF, van Mierlo T, Hengstman GJ et al. (2009) Increased plasma amyloid-beta42 protein in sporadic inclusion body myositis. Acta Neuropathol 118(3), 429-431.
30. Dalakas MC, Illa I, Gallardo E, Juarez C. (1997) Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations. Ann Neurol 41 (1), 100-104.
31. Needham M, Mastaglia FL, Garlepp MJ. (2007) Genetics of inclusion-body myositis. Muscle Nerve 35 (5), 549-561.
32. Mastaglia FL, Needham M, Scott A et al. (2009) Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscul Disord 19(11), 763-765.
33. Oh SJ, Claussen GC. (1995) Single-fiberEMGfindings in inclusion body myopathy. Muscle Nerve 18, 1050.
34. Dabby R, Lange DJ, TrojaborgWet al. (2001) Inclusion body myositis mimicking motor neuron disease. Arch Neurol 58(8), 1253-1256.
35. Luciano CA, Dalakas MC. (1997) Inclusion body myositis: no evidence for a neurogenic component. Neurology 48(1), 29-33.
36. Brannagan TH, Hays AP, Lange DJ, Trojaborg W. (1997) The role of quantitative electromyography in inclusion body myositis. J Neurol Neurosurg Psychiatry 63(6), 776-779.
37. Barkhaus PE, Periquet MI, Nandedkar SD. (1999) Quantitative electrophysiologic studies in sporadic inclusion body myositis. Muscle Nerve 22(4), 480-487.
38. Phillips BA, Cala LA, Thickbroom G.W et al. (2001) Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study. Muscle Nerve 24(11), 1526-1534.
39. Takamure M, Murata KY, Kawahara M, Ueno S. (2005) Finger flexor weakness in inclusion body myositis. Neurology 64(2), 389.
40. Fraser DD, Frank JA, DalakasMet al. (1991) Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 18(11), 1693-1700.
41. Sekul EA, Chow C, Dalakas MC. (1997) Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis. Neurology 48(4), 863-866.
42. Phillips BA, Mastaglia FL. (2002) Idiopathic inflammatory myopathies: epidemiology, classification and diagnostic criteria. Rheum Dis Clin N Am 28, 723-741.